The Family Medicine Psychiatry Toolkit: Modern Augmentation Strategies for Depression
Hilton Anaheim
777 West Convention Way
Anaheim, CA 92802
Monday, October 6, 2025 at 6:00am PT - 8:00am PT
Add this event to your calendar
Info
Topic
This program provides an in-depth educational review to help family medicine healthcare professionals effectively manage major depressive disorder (MDD). Explored topics include when to switch versus augment therapies, how and when to incorporate antipsychotics, and techniques for tailoring care to each patient’s unique needs.
Credits Offered
This event offers
1.5 contact hours
to attendees.
Accreditation Info:
ANCC.
Additional Information
Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners in an effort to optimize treatment for patients with major depressive disorder.
Target Audience
This activity is intended for healthcare professionals caring for patients with major depressive disorder, including physicians (psychiatrists and family medicine/primary care), nurse practitioners, and registered nurses.
Learning Objectives
Upon completion of this activity, participants should be able to:
-
Identify key criteria for deciding when to switch or augment medications in MDD according to best practice guidelines
-
Analyze the latest evidence supporting the use of antipsychotics in treating MDD
-
Distinguish between augmentation options in MDD based on their pharmacologic profiles
-
Develop a personalized treatment plan for MDD, tailored to individual patient needs and medication attributes
Speakers
Chief, Depression Research Clinic Director, Medical Student Education in Psychiatry Professor of Psychiatry and Behavioral Sciences Stanford University School of Medicine Stanford, California
Assistant Professor
Stanford School of Medicine
Department of Psychiatry and Behavioral Sciences
Palo Alto, California